Overview
- Flagship Pioneering is the first company to access the pathway, helping pilot the new model.
- The route provides coordinated, informal joint advice from MHRA and HSA to plan trials, avoid duplication, and cut delays.
- Priority areas include cancer, neurodegenerative disease, obesity, rare conditions, and advanced diagnostics without relaxing safety standards.
- The partnership includes joint work on AI in healthcare, with both agencies serving as pioneer countries in the HealthAI Global Regulatory Network and HSA’s chief joining the UK’s AI in healthcare commission.
- Officials say the initiative will support national health strategies, attract life‑sciences investment, and strengthen both countries as hubs for innovation.